Ironwood Pharmaceuticals Inc (FRA:I76)
€ 4.5 -0.04 (-0.88%) Market Cap: 713.95 Mil Enterprise Value: 1.21 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 56/100

Ironwood Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript

Jan 14, 2020 / 12:00AM GMT
Release Date Price: €11.2 (-0.88%)
Mark Mallon
Ironwood Pharmaceuticals, Inc. - CEO & Director

Good afternoon, everyone. Thanks, Eric, and thanks to JPMorgan for the opportunity to present this afternoon. I also want to thank my team that -- for the great work they've done over the last year and also in helping me be reasonably ready if things -- if this is a good presentation, that's all because of them. If it's not so good, that's because of me.

I was here a year ago, actually. And when I -- a year ago, I was actually basically literally 2 days into the job at Ironwood. And at that time, I'm sure I said, I know I said that I was really excited about the opportunities. And I can say a year later that I'm even more excited with the opportunities that we have at Ironwood, given what we've accomplished in 2019, which I'll take a few moments to go through and what we have as opportunities in front of us. And so hopefully, you'll also have a feeling about the possibilities for us to make a difference for GI patients and also to deliver value for shareholders and for our employees.

So this is our usual collection of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot